| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) (NCT05429970) | Memorial Sloan Kettering Cancer Center | 2022-06-17 |
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors (NCT05410717) | Second Affiliated Hospital of Guangzhou Medical University | 2022-06-01 |
| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer (NCT04811703) | Hospices Civils de Lyon | 2021-07-30 |
| Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy (NCT04204811) | Memorial Sloan Kettering Cancer Center | 2019-12-16 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites (NCT04267575) | Jerome Canady, M.D. | 2019-07-30 |
| 18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC) (NCT03811899) | University Health Network, Toronto | 2019-04-01 |
| Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03188432) | Wake Forest University Health Sciences | 2019-01-02 |
| PET Imaging of Ovarian Carcinoma With 18F-FSPG (NCT02872519) | Vanderbilt-Ingram Cancer Center | 2018-06-01 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02833506) | Roswell Park Cancer Institute | 2017-12-08 |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer (NCT03297489) | Roswell Park Cancer Institute | 2017-11-06 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery (NCT03029611) | University of Washington | 2017-04-03 |
| Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396) | National Cancer Institute (NCI) | 2016-06-01 |
| Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab (NCT00194714) | University of Washington | 2016-05-01 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent (NCT02470559) | Barbara Ann Karmanos Cancer Institute | 2015-06-01 |
| Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis (NCT02441140) | Dana-Farber Cancer Institute | 2015-05-01 |
| Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT02111941) | Mayo Clinic | 2014-04-14 |
| HOT: HIPEC in Ovarian Cancer as Initial Treatment (NCT02124421) | Mercy Medical Center | 2014-04-01 |
| Salvage Ovarian FANG™ Vaccine + Carboplatinum (NCT01867086) | Gradalis, Inc. | 2013-06-01 |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer (NCT01650376) | Swedish Medical Center | 2012-08-01 |
| Interactive Educational Website for Women With Ovarian Cancer & Caregivers (NCT01626014) | University of Minnesota | 2012-08-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer (NCT01275664) | Gynecologic Oncology Group | 2011-06-01 |
| Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer (NCT01196429) | National Cancer Institute (NCI) | 2010-08-01 |
| OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission (NCT00857545) | Gynecologic Oncology Group | 2010-07-01 |
| RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT01175343) | National Cancer Institute (NCI) | 2010-07-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (NCT01080521) | Gynecologic Oncology Group | 2010-04-01 |
| Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer (NCT02311907) | Alliance for Clinical Trials in Oncology | 2009-12-01 |
| Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126) | National Cancer Institute (NCI) | 2009-09-08 |
| Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00814086) | Gynecologic Oncology Group | 2009-02-01 |
| Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy (NCT00551265) | Gynecologic Oncology Group | 2007-10-01 |
| YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy (NCT00899093) | Gynecologic Oncology Group | 2007-09-01 |
| Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors (NCT00301756) | National Cancer Institute (NCI) | 2006-09-01 |
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer (NCT00352300) | Gynecologic Oncology Group | 2006-06-01 |
| Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00262847) | National Cancer Institute (NCI) | 2005-09-01 |
| Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients (NCT00316407) | Swedish Medical Center | 2005-08-01 |
| Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer (NCT01000259) | Gynecologic Oncology Group | 2004-09-01 |
| Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer (NCT00072566) | National Cancer Institute (NCI) | 2003-12-01 |
| Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00066456) | Gynecologic Oncology Group | 2003-09-01 |
| Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00060359) | Gynecologic Oncology Group | 2003-04-01 |
| Research Study in Patients With Advanced Ovarian Epithelial Cancer (NCT00053235) | Gynecologic Oncology Group | 2002-11-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00011986) | Gynecologic Oncology Group | 2001-01-01 |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer (NCT00003532) | Burzynski Research Institute | 1996-03-05 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |